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“The greater our knowledge increases, the greater our
ignorance unfolds.”
JF Kennedy
Address at Vanderbilt University Nashville, 
Tennessee, May 18 1963
As 2003 marches on one is left reflecting on yet another year
in which the intensive care literature has continued to
challenge the accepted tenets, and as always one continues
to be surprised by the results. The study conducted by
Finney and coworkers [1] illustrates well how our increasing
knowledge leads to more questions. Since the study by van
den Berghe and coworkers [2] was reported, much attention
has been given to rigorous control of blood glucose levels in
patients, although as Finney and coworkers [1] pointed out
the mechanisms underlying the perceived benefits are
unclear. In particular, the observed mortality reduction might
have been due to avoidance of hyperglycaemia or to the
dose of exogenous insulin, or perhaps a combination of the
two.
That observational study of 531 intensive care unit (ICU)
patients (523 studied) examined blood glucose levels and
quantity of insulin administered; a secondary question was to
determine whether there was a threshold glucose
concentration associated with increased mortality [1].
Glycaemic control was split into six bands that were
determined prospectively. The patients were predominantly
male, over 60 years old and overweight. Cardiac surgery was
the reason for admission in 85% of individuals, and
interestingly only 17 of the patients were judged to be
underweight. The relationship between ICU outcomes,
glucose control and insulin dose was modelled using
multivariable logistic regression. In all cases increased insulin
administration was associated with a significantly increased
risk for death. Despite the fact that over 16% of patients had
diabetes, this was not an independent risk factor. The
conclusions drawn were that it is the control of blood
glucose levels that account for any observed mortality
benefit, rather than intensive insulin therapy. The data also
implied that patients whose glucose levels remained
predominantly below 10mmol/l fared better than did those
patients whose glucose levels did not, and Finney and
coworkers speculated that a blood glucose level of less than
8.0mmol/l should be the preferred treatment aim.
The authors must be applauded for their honesty in that they
accept and demonstrate that glucose levels in the ICU are
difficult to control, in which we find some solace. This
excellent work joins the increasing body of evidence
highlighting the need for glycaemic control, although one is
left pondering the potential mechanisms that underlie the
observed effects. The study is also a triumph for
computerized clinical information systems, although the
authors do highlight the limitations of this approach. For
those of us who have often bemoaned the lack of high quality
data collection, the new millennium appears to have provided
an answer. We look forward to interrogating our relatively
new system!
From a study that examines a known risk factor for mortality,
we turn to one that attempts to predict it. Rocktaeschel and
coworkers [3] conducted a retrospective analysis of some
300 critically ill patients to determine whether various
acid–base parameters can predict mortality in such a group.
The principal thrust of the study was to determine whether
base excess, resulting either from unmeasured anions or from
anion gap, or both, can predict lactate concentrations.
Somewhat unsurprisingly, the overall conclusion was that
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these variables are good predictors of hyperlactaemia
(defined as >5mmol/l). The authors conceded that the
variables measured should correlate closely, given that they
may reflect the same entity.
Rocktaeschel and coworkers should be congratulated in that
this is a large study in a general ICU population, the median
age being 65.4 years and with a median Acute Physiology
and Chronic Health Evaluation II score of 17. As such the
results should be widely applicable in ICUs, and will be of
particular interest to those physicians who do not have ready
access to lactate measurements. The acid–base variables
studied, and specifically ‘unmeasured anions’, were not found
to be accurate predictors of in-hospital mortality in this group
of patients. The report joins the growing body of publications
‘measuring’ the unmeasured anions, but it is of interest in that
the authors also explained in part the various pitfalls in such
calculations and discussed the differences between
analytical methodologies. We wonder whether such
calculations will be of routine benefit in treating patients.
Indeed, Bronsted in 1923 led us away from the concept of
ions into the era of acids and bases. Given the difficulties
one occasionally experiences in instructing students
regarding the intricacies of acid–base balance, the concept
of unmeasured anions is often a bridge too far and at worst
can be somewhat anachronistic. At present we will stick to
the conventional measures of lactate, pH and base excess. If
the unmeasured anions are ever discovered (other than those
we are already aware of) and are found to be of prognostic
significance, then we will certainly think again.
Those involved in the intensive care arena often find
themselves making difficult, often end-of-life decisions based
on as much information as can be accrued. A recent study
attempted to address the decision processes involved in the
withdrawal of mechanical ventilation in anticipation of death
in ICU patients. Cook and coworkers [4] conducted a
prospective study, following adult patients admitted to
15 ICUs in Canada, the USA, Australia and Sweden. They
monitored continuous variables such as multiple organ
dysfunction score, use of invasive life support (mechanical
ventilation, inotropes, vasopressors, haemodialysis), do-not-
resuscitate orders, patient’s ability to participate in decision
making, physician’s prediction of survival and projected
status 1 month after discharge, as well as patient’s
preferences regarding use of invasive life support if known. A
total of 851 patients who were expected to be on the ICU for
at least 72 hours were enrolled, of whom 539 (63.3%) were
weaned from the ventilator, 146 (17.2%) died while receiving
ventilation and 166 (19.5%) had ventilation withdrawn.
Surprisingly, of the 166 patients who had ventilation
withdrawn, six survived to the point of discharge from
hospital. The main clinical characteristic of those who had
ventilation withdrawn was older age (64.4 years versus
60.1 years; P=0.02). Those who had ventilation withdrawn
were more likely to have do-not-resuscitate orders
established while they were in the ICU than were those who
died while on ventilation (100% versus 52.1%; P≤0.001).
They were also less likely to receive inotropes or
vasopressors (69.3% versus 89.7%; P≤0.001) and were
more likely to have these treatments withdrawn (62% versus
40.5%; P≤0.001). This group were also more likely to have
renal support withdrawn but were no more likely to have renal
support than were those who died while receiving ventilation.
There was no obvious correlation with admitting diagnosis or
organ system failure.
Interestingly, of the four independent factors associated with
withdrawal of mechanical ventilation, three were essentially
subjective judgements. These were the physician’s
perception of the patient’s preferences regarding use of life
support, the physician’s predictions of likelihood of survival in
the ICU, the physician’s predictions of the patient’s future
cognitive status, and the use of inotropes or vasopressors.
Moreover, there was no variation between centres, cities, or
countries. This is reassuring because it refutes the traditional
perception of withdrawal of life support based on age,
severity of illness and worsening organ function. However, it
is important to note that, more often than not, these were
perceived preferences, and information from family members
may be at odds with that from the patient. It is also apparent
that the way in which information is disseminated to the
family may influence the family’s decision. An intuitive view on
this article is provided by Drazen [5] and is a thoughtful
perspective.
Finally, we turn to a recent report that assessed the effects of
selective decontamination of the digestive tract (SDD) on
ICU and hospital mortality, as well as the subsequent
development, if any, of resistant bacteria [6]. That
randomized controlled study was conducted in 934 patients
who were expected to have a duration of stay of at least
72 hours. The patients were assigned either to polymyxin E,
tobramycin and amphotericin B together with an initial 4-day
course of intravenous cefotaxime, or to standard treatment.
There were no other significant differences between the
groups, and approximately 60% of patients had undergone
surgery. The ICU mortality was 15% in the SDD group and
23% in the control individuals. Similarly, in-hospital mortality
was 24% in the SDD group and 31% in control individuals,
with relative risks of 0.65 and 0.78, respectively. The median
ICU duration of stay was also reduced in the treated group.
Subsequent follow-up cultures, available in 773 patients,
revealed a reduction in resistant organisms in the treated
group as well as a reduction in antibiotic usage.
Astonishingly, no methicillin-resistant Staphylococcus aureus
was detected in either group, and one must therefore
congratulate the Dutch health service. Also, no differences
were observed between medical or surgical patients, despite
the fact that medical patients are more likely to be colonized
with resistant bacteria before ICU admission. However,
whether one adopts the routine use of SDD may well be404
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influenced by the local rates of resistant organisms. Over
2000 years ago, Hippocrates [7] had an interesting view on
therapy, stating that, ‘Extreme remedies are very appropriate
for extreme diseases.’ Who knows, perhaps he too would be
a modern day advocate of SDD!
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